UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.587

Sortiert nach

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

British journal of cancer, 2011-08, Vol.105 (5), p.628-639

2011

Volltextzugriff (PDF)

Radiovirotherapy: principles and prospects in oncology

Current pharmaceutical design, 2012, Vol.18 (22), p.3313

2012

Volltextzugriff (PDF)

OX40 and 4-1BB delineate distinct immune profiles in sarcoma

Oncoimmunology, 2022-12, Vol.11 (1), p.2066050-2066050

2022

Volltextzugriff (PDF)

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Gene therapy, 2009-05, Vol.16 (5), p.689-699

2009

Volltextzugriff (PDF)

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

Gene therapy, 2008-06, Vol.15 (12), p.911-920

2008

Volltextzugriff (PDF)

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma

Annals of oncology, 2009-07, Vol.20 (7), p.1275-1279

2009

Volltextzugriff (PDF)

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

British journal of cancer, 2011-08, Vol.105 (5), p.618-627

2011

Volltextzugriff (PDF)

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers

British journal of radiology, 2012-05, Vol.85 (1013), p.487-494

2012

Volltextzugriff (PDF)

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

Gene therapy, 2008-09, Vol.15 (18), p.1257-1270

2008

Volltextzugriff (PDF)

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy

British journal of cancer, 2009-06, Vol.100 (12), p.1889-1895

2009

Volltextzugriff (PDF)

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

British journal of cancer, 2006-03, Vol.94 (5), p.631-636

2006

Volltextzugriff (PDF)

Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-04, Vol.29 (4), p.263-273

2017

Volltextzugriff (PDF)

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy

Gene therapy, 2013-05, Vol.20 (5), p.521-528

2013

Volltextzugriff (PDF)

The effect of parotid gland‐sparing intensity‐modulated radiotherapy on salivary composition, flow rate and xerostomia measures

Oral diseases, 2017-10, Vol.23 (7), p.990-1000

2017

Volltextzugriff (PDF)

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

Oral oncology, 2013-02, Vol.49 (2), p.108-118

2013

Volltextzugriff (PDF)

Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: A matched-pair analysis

Oral oncology, 2013-06, Vol.49 (6), p.615-619

2013

Volltextzugriff (PDF)

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer

British journal of cancer, 2008-07, Vol.99 (1), p.57-62

2008

Volltextzugriff (PDF)

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

British journal of cancer, 2012-01, Vol.106 (3), p.496-507

2012

Volltextzugriff (PDF)

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer

Annals of oncology, 2001-04, Vol.12 (4), p.493-496

2001

Volltextzugriff (PDF)

Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer

British journal of radiology, 2009-07, Vol.82 (979), p.585-594

2009

Volltextzugriff (PDF)

Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?

Gene therapy, 2010-08, Vol.17 (8), p.949-960

2010

Volltextzugriff (PDF)

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Annals of oncology, 2018-10, Vol.29, p.viii729-viii729

2018

Volltextzugriff (PDF)

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer

Gene therapy, 2005-02, Vol.12 (3), p.272-280

2005

Volltextzugriff (PDF)

The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-10, Vol.25 (10), p.569-577

2013

Volltextzugriff (PDF)

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

Oral oncology, 2014-02, Vol.50 (2), p.141-146

2014

Volltextzugriff (PDF)

1 – 25 von 2.587

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.275)
Mit Volltextzugriff
(2.338)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.625)
Life Sciences & Biomedicine
(1.295)
Humans
(1.062)
Female
(659)
Male
(586)
Biological And Medical Sciences
(577)
Medical Sciences
(488)
Middle Aged
(415)
Aged
(317)
Adult
(316)
Animals
(254)
Physical Sciences
(254)
Cardiovascular System & Cardiology
(189)
Oncology
(187)
Cardiac & Cardiovascular Systems
(170)
Treatment Outcome
(143)
Adolescent
(137)
Risk Factors
(137)
Public, Environmental & Occupational Health
(122)
Fundamental And Applied Biological Sciences. Psychology
(120)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

Radiovirotherapy: principles and prospects in oncology

OX40 and 4-1BB delineate distinct immune profiles in sarcoma

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy

The effect of parotid gland‐sparing intensity‐modulated radiotherapy on salivary composition, flow rate and xerostomia measures

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: A matched-pair analysis

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer

Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer

Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer

The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

Suchergebnisse filtern